Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CDMO Great Bay Bio Founded | Contract Pharma

What are you searching for?

Sign in
Breaking News

CDMO Great Bay Bio Founded

To build platform for CMC technology and pre-clinical R&D; names Michael Chan as CEO

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Great Bay Bio, a new biotechnology company dedicated to innovative drug CMC (Chemistry Manufacturing and Controls) and pre-clinical development of big data service platform, has been established in Hong Kong.
 
Dr. Michael Chan has been named chief executive officer. He will be tasked with formulating a sustainable development strategy for Great Bay Bio and be responsible for the overall operation and management of the enterprise. The headquarters will be based in Hong Kong and expand its business domestically and internationally. The company currently focuses on two major business lines: CMC platform technology services and product development, including two subsidiaries—Dongguan Taili Biotech and Guangdong Taili Biomedical Technology.
 
Great Bay Bio’s service platform of CMC/CDMO technology and pre-clinical research and big data development has a technical team of over 40 scientists and investigators. The team will offer an integrated service package with variability and customization.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics